A kind of imino acid specific endoprotease compound enzyme preparation and preparation method

By preparing compound enzyme preparations containing hydroxyproline-specific endoproteinase and other auxiliary components, and using lyophilization and vacuum treatment techniques, the problem of inactivation of hydroxyproline-specific endode during preservation is solved. , realizes long-term high activity preservation of enzymes.

CN118048353BActive Publication Date: 2024-12-03HAINAN HUAYAN BIOTECH
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410260668.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-07
Publication Date
2024-12-03
Estimated Expiration
2044-03-07

AI Technical Summary

Technical Problem

Hydroxyproline-specific endonuclease is prone to inactivate during preservation, affecting its application time and activity.

Method used

Using imino acid-specific endoproteinase complex enzyme preparations, including hydroxyproline-specific endoproteinase, compound manganese salt, Centella asiatica saponin, pH buffering regulator, fillers, sugars and surfactants, through A specific lyophilization and vacuum treatment method is used to prepare stable enzyme preparations.

Benefits of technology

It extends the storage time of hydroxyproline-specific endoproteinase, improves the activity retention rate of enzymes, and ensures high activity performance during long-term use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004730798950000091
    Figure BDA0004730798950000091
  • Figure BDA0004730798950000101
    Figure BDA0004730798950000101
Patent Text Reader

Abstract

The present invention relates to the technical field of imino acid-specific endoproteases, and discloses an imino acid-specific endoprotease compound enzyme preparation and a preparation method thereof, wherein each component is measured by mass, and comprises 20-35 parts of imino acid-specific endoproteases, 2-8 parts of compound manganese salts, 2-5 parts of asiaticoside, 0.1-3 parts of pH buffer regulators, 0.1-3 parts of fillers, 0.1-2.5 parts of carbohydrates, 0.1-1.5 parts of surfactants and 0.01-0.5 parts of potassium sorbate. The present invention adopts an imino acid-specific endoprotease compound enzyme preparation of the above-mentioned components, and the hydroxyproline-specific protease has a long storage time and a high activity retention rate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of imino acid specific endoprotease, in particular to an imino acid specific endoprotease composite enzyme preparation and a preparation method thereof. Background Art

[0002] Hydroxyproline (HYP) is one of the imino acids, a non-essential amino acid, one of the main components of collagen tissue, and a unique amino acid in collagen, accounting for about 13% of the total collagen amino acids. Collagen is the most abundant protein in the body, accounting for about 1 / 3 of the total protein in the human body. By taking advantage of the fact that hydroxyproline has the highest content in collagen, the determination of hydroxyproline in blood and urine can be used to understand the decomposition and metabolism of collagen in the body, which can be used as an indicator of the decomposition of connective tissue.

[0003] HYP is not a substrate for synthesizing collagen, but it is necessary to maintain the three-dimensional helical structure of collagen, and can enhance the thermal stability of collagen and inhibit the occurrence of protein aggregation and fibrosis. Many studies have shown that exogenous addition of proline (Pro), hydroxyproline (HYP), vitamin C, glutamine and α-ketoglutaric acid has a certain effect on collagen deposition in animals.

[0004] Hydroxyproline specific endonuclease is a type of cleavage enzyme that specifically degrades the carboxyl terminal peptide bond of hydroxyproline residues. It can specifically recognize and hydrolyze the carboxyl terminal peptide bond of the proline residue in the polypeptide to degrade proline. At present, hydroxyproline specific endonuclease is inactivated in the early stage during the storage process, which seriously affects the application of hydroxyproline specific endonuclease. Therefore, it is necessary to study how to improve the storage time and enzyme activity of hydroxyproline specific endonuclease. Summary of the invention

[0005] The purpose of the present invention is to provide an imino acid specific endoprotease compound enzyme preparation and a preparation method thereof. The hydroxyproline specific protease has a long storage time and a high activity retention rate.

[0006] To achieve the above-mentioned purpose, the present invention provides an amino acid-specific endoprotease complex enzyme preparation, wherein the components, by weight, include 20-35 parts of amino acid-specific endoprotease, 2-8 parts of complex manganese salt, 2-5 parts of Centella asiatica saponin, 0.1-3 parts of pH buffer regulator, 0.1-3 parts of filler, 0.1-2.5 parts of sugar, 0.1-1.5 parts of surfactant and 0.01-0.5 parts of potassium sorbate.

[0007] Preferably, the filler includes one or more of mannitol, glycine, hydroxymethylcellulose, and gelatin.

[0008] Preferably, the pH buffering agent includes one or more of Tris-HCl, sodium dihydrogen phosphate-citric acid, potassium dihydrogen phosphate, citric acid-sodium citrate and histidine.

[0009] Preferably, the sugar includes one or more of trehalose, sucrose, glucose, inulin and sodium hyaluronate.

[0010] Preferably, the surfactant includes one or more of Tween-80, Tween-20, sodium dodecyl sulfate, Triton X-100, and sucrose fatty acid ester.

[0011] Preferably, the compound manganese salt includes one or more of manganese sulfate, manganese chloride, manganese phosphate, manganese acetate, and manganese silicate.

[0012] Preferably, the concentration of the compound manganese salt is 0.5-6mmol / L.

[0013] Preferably, the pH range adjusted by the pH buffering agent is 6.0-8.2.

[0014] Preferably, the imino acid-specific endoprotease is a hydroxyproline-specific endoprotease, and the hydroxyproline-specific endoprotease is derived from Aspergillus flavus.

[0015] The preparation method of the above-mentioned imino acid specific endoprotease complex enzyme preparation comprises the following steps:

[0016] S1, extracting hydroxyproline-specific protease from Aspergillus flavus, purifying and concentrating to obtain a hydroxyproline-specific protease solution;

[0017] S2, weighing 0.1-3 parts of pH buffer regulator, 0.1-3 parts of filler, 0.1-2.5 parts of sugar, 0.1-1.5 parts of surfactant and 0.01-0.5 parts of potassium sorbate according to mass ratio, mixing well and dissolving in pure water to obtain a lyophilization protective agent;

[0018] S3, the hydroxyproline specific protease solution in S1 and the lyophilized protective agent in S2 are mixed and pre-frozen, maintained at -25 to -15°C for 1.5-4.5 hours and a vacuum degree of 0 mbar, maintained at -35 to -15°C for 5-10 hours and a vacuum degree of 0.3-0.5 mbar, maintained at -5 to 5°C for 3-5 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 0 to 10°C for 0.5 to 3 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 5 to 15°C for 0.5 to 3.5 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 10 to 20°C for 7 to 10 hours and a vacuum degree of 0.3-0.5 mbar;

[0019] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained;

[0020] S4. Under an inert atmosphere, add 2-8 parts of compound manganese salt and 2-5 parts of Centella asiatica saponin to the lyophilized powder of hydroxyproline-specific endoprotease in S3, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, package it in a glass bottle, and put it into storage after quality inspection.

[0021] Therefore, the present invention adopts an amino acid-specific endoprotease complex enzyme preparation of the above-mentioned components, and its beneficial effects are: the storage time of the hydroxyproline-specific endoprotease is long, the activity retention rate of the hydroxyproline-specific protease is high after long-term storage, and the complex manganese salt improves the activity of the hydroxyproline-specific protease, and has excellent performance when used.

[0022] The technical solution of the present invention is further described in detail below through embodiments. DETAILED DESCRIPTION

[0023] The technical solution of the present invention is further illustrated by the following examples.

[0024] The present invention can be explained in more detail by the following examples. The purpose of disclosing the present invention is to protect all changes and improvements within the scope of the present invention. The present invention is not limited to the following examples.

[0025] Example 1

[0026] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0027] S2. Weigh 3 parts of Tris-HCl, 1.5 parts of glycine, 2.5 parts of sodium hyaluronate and sucrose, 0.8 parts of TritonX-100 and 0.05 parts of potassium sorbate according to the mass ratio, mix them evenly and dissolve them in pure water to obtain a lyophilization protective agent.

[0028] S3. The hydroxyproline-specific protease solution in S1 and the lyophilized protective agent in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -25°C for 3 h and a vacuum degree of 0 mbar, maintained at -35°C for 9 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 4 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 2.5 h and a vacuum degree of 0.3 mbar, maintained at 6°C for 3.5 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 7 h and a vacuum degree of 0.3 mbar.

[0029] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0030] S4. Under an inert atmosphere, add 6 parts of manganese sulfate and manganese chloride (v / v, 3 / 2) to the lyophilized powder of hydroxyproline-specific endoprotease in S3, the concentration of the compound manganese salt is 1.0 mmol / L, and 3 parts of Centella asiatica saponin, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, put it into a glass bottle for packaging, and put it into storage after quality inspection.

[0031] Example 2

[0032] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0033] S2. Weigh 2.5 parts of sodium dihydrogen phosphate-citric acid, 2 parts of hydroxymethyl cellulose, 1.5 parts of trehalose and sucrose, 0.5 parts of Tween-80 and 0.02 parts of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a lyophilization protective agent.

[0034] S3. The hydroxyproline-specific protease solution in S1 and the lyophilized protective agent in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -20°C for 3.5 h and a vacuum degree of 0 mbar, maintained at -30°C for 10 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 3.5 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 8°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 15°C for 7 h and a vacuum degree of 0.3 mbar.

[0035] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0036] S4. Under an inert atmosphere, add 5 parts of manganese phosphate and manganese acetate (v / v, 5 / 5) to the lyophilized powder of hydroxyproline-specific endoprotease in S3, the concentration of the compound manganese salt is 1.5 mmol / L, and 5 parts of Centella asiatica saponin, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, put it into a glass bottle for packaging, and put it into storage after quality inspection.

[0037] Example 3

[0038] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0039] S2. Weigh 2.5 parts of citric acid-sodium citrate, 1.5 parts of mannitol, 2 parts of sucrose and glucose, 1.2 parts of sodium dodecyl sulfate and 0.01 part of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a freeze-drying protective agent with a pH range of 6.0-8.2.

[0040] S3. The hydroxyproline-specific protease solution in S1 and the lyophilized protective agent in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -25°C for 3 h and a vacuum degree of 0 mbar, maintained at -35°C for 9 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 4 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 2.5 h and a vacuum degree of 0.3 mbar, maintained at 6°C for 3.5 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 7 h and a vacuum degree of 0.3 mbar.

[0041] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0042] S4. Under an inert atmosphere, add 8 parts of manganese acetate and manganese silicate (v / v, 2 / 5) to the lyophilized powder of hydroxyproline-specific endoprotease in S3, the concentration of the composite manganese salt is 3.0 mmol / L, and 5 parts of Centella asiatica saponin, mix to obtain a hydroxyproline-specific endoprotease composite enzyme preparation, put it into a glass bottle for packaging, and put it into storage after quality inspection.

[0043] Example 4

[0044] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0045] S2. Weigh 1.8 parts of histidine, 1.6 parts of glycine, 2 parts of sodium hyaluronate, 1.0 part of sucrose fatty acid ester and 0.01 part of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a lyophilization protective agent.

[0046] S3. The hydroxyproline-specific protease solution in S1 and the lyophilized protective agent in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -20°C for 3.5 h and a vacuum degree of 0 mbar, maintained at -30°C for 10 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 8°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 15°C for 7 h and a vacuum degree of 0.3 mbar.

[0047] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0048] S4. Under an inert atmosphere, add 6 parts of manganese chloride and manganese phosphate (v / v, 4 / 5) to the lyophilized powder of hydroxyproline-specific endoprotease in S3, the concentration of the compound manganese salt is 4.0 mmol / L, and 2 parts of Centella asiatica saponin, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, put it into a glass bottle for packaging, and put it into storage after quality inspection.

[0049] Example 5

[0050] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0051] S2. Weigh 1.2 parts of sodium dihydrogen phosphate-citric acid, 2.0 parts of gelatin, 1.8 parts of sucrose and inulin, 1.2 parts of Tween-20 and 0.01 parts of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a lyophilization protective agent.

[0052] S3. The hydroxyproline-specific protease solution in S1 and the lyoprotectant in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -20°C for 3.5 h and a vacuum degree of 0 mbar, maintained at -30°C for 10 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 2.5 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 10 h and a vacuum degree of 0.3 mbar.

[0053] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0054] S4. Under an inert atmosphere, add 7 parts of manganese phosphate, manganese acetate and manganese silicate (v / v / v, 2 / 3 / 5) to the lyophilized powder of hydroxyproline-specific endoprotease in S3, the concentration of the compound manganese salt is 5.0 mmol / L, and 5 parts of Centella asiatica saponin, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, put it into a glass bottle for packaging, and put it into storage after quality inspection.

[0055] Comparative Example 1

[0056] The imino acid specific endoprotease is a hydroxyproline specific endoprotease. The hydroxyproline specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification, and the dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline specific protease solution is obtained, and the enzyme activity is detected. 7 parts of manganese phosphate, manganese acetate and manganese silicate (v / v / v, 2 / 3 / 5) are added, the concentration of the composite manganese salt is 1.0 mmol / L, and 5 parts of Centella asiatica saponin are added, and the hydroxyproline specific endoprotease composite enzyme preparation solution is obtained after mixing.

[0057] Comparative Example 2

[0058] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0059] S2. Weigh 1.2 parts of sodium dihydrogen phosphate-citric acid, 2.0 parts of gelatin, 1.8 parts of sucrose and inulin, 1.2 parts of Tween-20 and 0.01 parts of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a lyophilization protective agent.

[0060] S3. The hydroxyproline-specific protease solution in S1 and the lyoprotectant in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -20°C for 3.5 h and a vacuum degree of 0 mbar, maintained at -30°C for 10 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 2.5 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 10 h and a vacuum degree of 0.3 mbar.

[0061] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0062] S4. Under an inert atmosphere, add 5 parts of Centella asiatica saponin to the hydroxyproline-specific endoprotease freeze-dried powder in S3, mix to obtain a hydroxyproline-specific endoprotease complex enzyme preparation, package it in a glass bottle, and put it into storage after quality inspection.

[0063] Comparative Example 3

[0064] S1. The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease. The hydroxyproline-specific protease is extracted from Aspergillus flavus, purified and concentrated, and a dialysis bag is used for purification. The dialysis is performed into a buffer solution with a pH of 6.8-7.2. After multiple dialysis, a hydroxyproline-specific protease solution is obtained, and the enzyme activity is detected.

[0065] S2. Weigh 1.2 parts of sodium dihydrogen phosphate-citric acid, 2.0 parts of gelatin, 1.8 parts of sucrose and inulin, 1.2 parts of Tween-20 and 0.01 parts of potassium sorbate according to the mass ratio, mix well and dissolve in pure water to obtain a lyophilization protective agent.

[0066] S3. The hydroxyproline-specific protease solution in S1 and the lyoprotectant in S2, with a pH range of 6.0-8.2, are mixed and pre-frozen, maintained at -20°C for 3.5 h and a vacuum degree of 0 mbar, maintained at -30°C for 10 h and a vacuum degree of 0.3 mbar, maintained at -5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 5°C for 3 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 2.5 h and a vacuum degree of 0.3 mbar, maintained at 12°C for 10 h and a vacuum degree of 0.3 mbar.

[0067] After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained.

[0068] S4. Under an inert atmosphere, add 5.0 mmol / L composite zinc salt, 7 parts of zinc phosphate, zinc acetate and zinc silicate (v / v / v, 2 / 3 / 5), and 5 parts of Centella asiatica saponin to the lyophilized powder of hydroxyproline-specific endoprotease in S3, mix to obtain a composite enzyme preparation of hydroxyproline-specific endoprotease, package it in a glass bottle, and put it into storage after quality inspection.

[0069] Test Example 1

[0070] Enzyme activity detection

[0071] a. Take 5 μL of the hydroxyproline specific protease solution obtained in Examples 1-5 and Comparative Example 1S1 and 5 μL of the hydroxyproline specific protease complex enzyme solution in S4 after being placed at low temperature for one month, add 200 μL of buffer (pH=6.8-7.2) and mix, water bath at 37°C for 8 min, add 20 μL of substrate Z-Gly-Pro-pNA solution, mix well, react in a water bath at 37°C for 15 min, and then immediately boil in a water bath for 10 min. After cooling, draw the reaction solution into a well plate, use a microplate reader to measure the absorbance at 410 nm, and calculate the enzyme activity retention rate. The results are shown in Table 1.

[0072] Table 1. Data table of enzyme activity retention rates before and after placement of Examples 1-5 and Comparative Example 1

[0073]

[0074] b. Take 5 μL of the hydroxyproline-specific protease complex enzyme solution in S4 after being placed at low temperature for one month in Example 5, Comparative Example 2 and Comparative Example 3, respectively, add 200 μL of buffer (pH=6.8-7.2) and mix, water bath at 37°C for 8 minutes, add 20 μL of substrate Z-Gly-Pro-pNA solution, mix well, react in a water bath at 37°C for 15 minutes, and then immediately boil in a water bath for 10 minutes. After cooling, draw the reaction solution into a well plate, and use an ELISA reader to measure the absorbance at 410 nm. The results are shown in Table 2.

[0075] Table 2. Activity value data of compound enzyme preparations after standing in Example 5 and Comparative Example 2-3

[0076] Example 5 Comparative Example 2 Comparative Example 3 Vitality value (U / ml) 5.28 2.41 1.37

[0077] c. Place the hydroxyproline specific protease compound enzyme preparation in Example 1-5 for half a month, one month, two months and three months, take 5 μL of the hydroxyproline specific protease compound enzyme preparation solution of each time period, add 200 μL of buffer (pH=6.8-7.2) to mix, water bath at 37°C for 8min, add 20 μL of substrate Z-Gly-Pro-pNA solution, react in a water bath at 37°C for 15min after mixing, and then immediately boil in a water bath for 10min. After cooling, draw the reaction solution into the well plate, use a microplate reader to measure the absorbance at 410nm, and the results are shown in Table 3.

[0078] Table 3. Activity value data of the composite enzyme preparations in Examples 1-5 at different storage times

[0079]

[0080] As shown in Table 1-3, the hydroxyproline-specific endoprotease complex enzyme preparation obtained in Example 1-5 has a high activity value retention rate within three months, and the activity value of the hydroxyproline-specific endoprotease complex enzyme preparation is excellent.

[0081] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that they can still modify or replace the technical solution of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solution to deviate from the spirit and scope of the technical solution of the present invention.

Claims

1. An imino acid specific endoprotease complex enzyme preparation, characterized in that: The components include, by weight, 20-35 parts of imino acid specific endoprotease, 2-8 parts of compound manganese salt, 2-5 parts of Centella asiatica saponin, 0.1-3 parts of pH buffer regulator, 0.1-3 parts of filler, 0.1-2.5 parts of sugar, 0.1-1.5 parts of surfactant and 0.01-0.5 parts of potassium sorbate; The compound manganese salts include manganese sulfate and manganese chloride; manganese phosphate and manganese acetate; manganese acetate and manganese silicate; manganese chloride and manganese phosphate; one of manganese phosphate, manganese acetate and manganese silicate; The imino acid-specific endoprotease is a hydroxyproline-specific endoprotease, and the hydroxyproline-specific endoprotease is derived from Aspergillus flavus.

2. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The filler includes one or more of mannitol, glycine, hydroxymethylcellulose, and gelatin.

3. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The pH buffering agent includes one or more of Tris-HCl, sodium dihydrogen phosphate-citric acid, potassium dihydrogen phosphate, citric acid-sodium citrate and histidine.

4. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The sugars include one or more of trehalose, sucrose, glucose, inulin and sodium hyaluronate.

5. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The surfactant includes one or more of Tween-80, Tween-20, sodium dodecyl sulfate, TritonX-100, and sucrose fatty acid ester.

6. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The concentration of the compound manganese salt is 0.5-6mmol / L.

7. The imino acid-specific endoprotease complex enzyme preparation according to claim 1, characterized in that: The pH range adjusted by the pH buffer is 6.0-8.

2.

8. A method for preparing an imino acid specific endoprotease complex enzyme preparation according to any one of claims 1 to 7, characterized in that: The following steps are included: S1, extracting hydroxyproline-specific protease from Aspergillus flavus, purifying and concentrating to obtain a hydroxyproline-specific protease solution; S2, weighing 0.1-3 parts of pH buffer regulator, 0.1-3 parts of filler, 0.1-2.5 parts of sugar, 0.1-1.5 parts of surfactant and 0.01-0.5 parts of potassium sorbate according to mass ratio, mixing well and dissolving in pure water to obtain a lyophilization protective agent; S3, the hydroxyproline specific protease solution in S1 and the lyophilized protective agent in S2 are mixed and pre-frozen, maintained at -25 to -15°C for 1.5-4.5 hours and a vacuum degree of 0 mbar, maintained at -35 to -15°C for 5-10 hours and a vacuum degree of 0.3-0.5 mbar, maintained at -5 to 5°C for 3-5 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 0 to 10°C for 0.5 to 3 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 5 to 15°C for 0.5 to 3.5 hours and a vacuum degree of 0.3-0.5 mbar, maintained at 10 to 20°C for 7 to 10 hours and a vacuum degree of 0.3-0.5 mbar; After the freeze-drying is completed, the hydroxyproline-specific endoprotease freeze-dried powder is obtained; S4. Under an inert atmosphere, add 2-8 parts of compound manganese salt and 2-5 parts of Centella asiatica saponin to the lyophilized powder of hydroxyproline-specific endoprotease in S3, mix to obtain a hydroxyproline-specific endoprotease compound enzyme preparation, package it in a glass bottle, and put it into storage after quality inspection.

Citation Information

Patent Citations

  • Novel proline specific endoprotease gene and application thereof

    CN103589741A

  • Liquid proline specific endo protease compound enzyme preparation

    CN104560933A

  • Protein formulations containing amino acids

    US20140127227A1

  • Dried compositions containing flap endonuclease

    US20200071760A1